# A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers

> **NCT01654211** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 33 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** danoprevir
- **DRUG:** danoprevir
- **DRUG:** placebo
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT01654211
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654211, "A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01654211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*